{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:45Z","timestamp":1791409905958,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 22477114"],"award-info":[{"award-number":["No. 22477114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82020108030"],"award-info":[{"award-number":["No. 82020108030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82204213"],"award-info":[{"award-number":["No. 82204213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20416"],"award-info":[{"award-number":["U21A20416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["262102311196"],"award-info":[{"award-number":["262102311196"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300421127"],"award-info":[{"award-number":["252300421127"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300420519"],"award-info":[{"award-number":["252300420519"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742581"],"award-info":[{"award-number":["2023M742581"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110366","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:19:29Z","timestamp":1786465169000},"page":"110366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological inhibition of LSD1 suppresses the CD155\/TIGIT immune checkpoint axis and enhances NK cell-mediated cytotoxicity in colorectal cancer"],"prefix":"10.1016","volume":"181","author":[{"given":"Xing-Jie","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-wan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Man","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2026.110366_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065588","article-title":"From biology to diagnosis and treatment: the Ariadne\u2019s thread in cancer of unknown primary","volume":"24","author":"Mathew","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6349","key":"10.1016\/j.bioorg.2026.110366_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.bioorg.2026.110366_bb0015","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110366_bb0020","doi-asserted-by":"crossref","first-page":"1176950","DOI":"10.3389\/fonc.2023.1176950","article-title":"Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements","volume":"13","author":"Cann","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110366_bb0025","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.bioorg.2026.110366_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17132125","article-title":"Immune checkpoint inhibitors for metastatic colorectal cancer: a systematic review","volume":"17","author":"Gilson","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110366_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/pme-2021-0128","article-title":"Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls","volume":"19","author":"Adeleke","year":"2022","journal-title":"Pers. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3393\/ac.2025.01354.0193","article-title":"Immunotherapy for microsatellite-stable colorectal cancer: overcoming resistance and exploring novel therapeutic strategies","volume":"42","author":"Kim","year":"2026","journal-title":"Annals Coloproctol."},{"key":"10.1016\/j.bioorg.2026.110366_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111896","article-title":"CD155 as an emerging target in tumor immunotherapy","volume":"131","author":"Wu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.110366_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2019.11.013","article-title":"Tumor intrinsic and extrinsic immune functions of CD155","volume":"65","author":"O'Donnell","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.110366_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215830","article-title":"CD155 in tumor progression and targeted therapy","volume":"545","author":"Zhan","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41419-025-07984-4","article-title":"TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies","volume":"16","author":"Cui","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110366_bb0065","doi-asserted-by":"crossref","first-page":"1568664","DOI":"10.3389\/fphar.2025.1568664","article-title":"Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy","volume":"16","author":"Ghasemi","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110366_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13082038","article-title":"Agnostic biomarkers and molecular signatures in colorectal Cancer-guiding chemotherapy and predicting response","volume":"13","author":"Kyrochristou","year":"2025","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110366_bb0075","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/0008-5472.CAN-25-0733","article-title":"Base editing of TIGIT reprograms CD155 Signaling in natural killer cells to enhance Cancer immunotherapy efficacy","volume":"86","author":"Fang","year":"2026","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110366_bb0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110366_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115255","article-title":"Discovery of acridine-based LSD1 inhibitors as immune activators targeting LSD1 in gastric cancer","volume":"251","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110366_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115684","article-title":"Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancer","volume":"259","author":"Dai","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110366_bb0095","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/neuonc\/noaa058","article-title":"Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma","volume":"22","author":"Bailey","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12934","article-title":"Roadmap to a plasma cell: epigenetic and transcriptional cues that guide B cell differentiation","volume":"300","author":"Wiggins","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bioorg.2026.110366_bb0105","article-title":"LSD1 in drug discovery: from biological function to clinical application","author":"Liu","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s43556-025-00373-5","article-title":"Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications","volume":"6","author":"Ma","year":"2025","journal-title":"Mol. Biomed."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110366_bb0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/13543776.2026.2636040","article-title":"LSD1 inhibitors for anticancer therapy: an updated patent review (2022-2025)","volume":"36","author":"Zhang","year":"2026","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0125","article-title":"Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulation","volume":"11","author":"Wang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12943-025-02311-z","article-title":"LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in BRAF mutant colorectal cancer","volume":"24","author":"Ladaika","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110366_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70335","article-title":"Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer","volume":"15","author":"Liang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.110366_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110366_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225610","article-title":"CD155 cooperates with PD-1\/PD-L1 to promote proliferation of Esophageal squamous cancer cells via PI3K\/Akt and MAPK Signaling pathways","volume":"14","author":"Tang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12964-023-01455-z","article-title":"The immune checkpoint TIGIT\/CD155 promotes the exhaustion of CD8+T cells in TNBC through glucose metabolic reprogramming mediated by PI3K\/AKT\/mTOR signaling","volume":"22","author":"Huang","year":"2024","journal-title":"Cell Commun. Signal. CCS"},{"issue":"35","key":"10.1016\/j.bioorg.2026.110366_bb0155","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.2174\/092986710793361234","article-title":"PI3K\/Akt\/mTOR pathway inhibitors in cancer: a perspective on clinical progress","volume":"17","author":"Wu","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110366_bb0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00280-012-2043-3","article-title":"Overcoming acquired resistance to anticancer therapy: focus on the PI3K\/AKT\/mTOR pathway","volume":"71","author":"Burris","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110366_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.20892\/j.issn.2095-3941.2018.0253","article-title":"The PI3K\/Akt\/GSK-3\u03b2\/ROS\/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility","volume":"16","author":"Jin","year":"2019","journal-title":"Cancer Biol. Med."},{"issue":"57","key":"10.1016\/j.bioorg.2026.110366_bb0170","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1038\/sj.onc.1208122","article-title":"ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)","volume":"23","author":"Epling-Burnette","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110366_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12050932","article-title":"LncRNA biomarkers of glioblastoma multiforme","volume":"12","author":"Pokorn\u00e1","year":"2024","journal-title":"Biomedicines"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:13:57Z","timestamp":1791407637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0045206826009028"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110366","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of LSD1 suppresses the CD155\/TIGIT immune checkpoint axis and enhances NK cell-mediated cytotoxicity in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110366"}}